Insider · CIK 0001646626
Lakhmir S Chawla
Files at REVB (REVELATION BIOSCIENCES, INC.). First filing -, latest -.
In brief
Lakhmir S Chawla files SEC Form 4 as director at REVB (REVELATION BIOSCIENCES, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Lakhmir S Chawla has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 17, 2026 | REVB REVELATION BIOSCIENCES, INC. | AGrant or award Common Stock | +32,011 | $0.00 | $0 | 44,169 | Aug 18, 2026 |
| Feb 3, 2026 | REVB REVELATION BIOSCIENCES, INC. | FTax withholding Common Stock | -2,261 | $1.85 | $4,183 | 12,158 | Feb 5, 2026 |
| Jan 8, 2026 | REVB REVELATION BIOSCIENCES, INC. | AGrant or award Common Stock | +41,981 | $0.90 | $38k | 57,667 | Jan 12, 2026 |
| Oct 29, 2025 | REVB REVELATION BIOSCIENCES, INC. | AGrant or award Common Stock | +15,625 | $1.28 | $20k | 15,686 | Oct 31, 2025 |
| Feb 11, 2025 | REVB REVELATION BIOSCIENCES, INC. | AGrant or award Common Stock | +181 | $3.87 | $700 | 181 | Feb 13, 2025 |
Questions about Lakhmir S Chawla
Answered from the filings on this page, as of the latest one.
Is Lakhmir S Chawla buying or selling?
Lakhmir S Chawla has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Lakhmir S Chawla's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Lakhmir S Chawla has 0.
Where does Lakhmir S Chawla file Form 4?
Lakhmir S Chawla has filed Form 4 at REVB (REVELATION BIOSCIENCES, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.